Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 47% ± 20% | |
lung | 10 studies | 32% ± 10% | |
eye | 9 studies | 30% ± 16% | |
peripheral blood | 5 studies | 28% ± 6% | |
heart | 5 studies | 25% ± 7% | |
kidney | 5 studies | 23% ± 8% | |
intestine | 4 studies | 23% ± 6% | |
uterus | 4 studies | 28% ± 9% | |
adipose | 4 studies | 35% ± 12% | |
placenta | 3 studies | 32% ± 14% | |
liver | 3 studies | 31% ± 13% | |
prostate | 3 studies | 23% ± 5% | |
skin | 3 studies | 25% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7009.90 | 1445 / 1445 | 100% | 38.16 | 183 / 183 |
brain | 100% | 11444.53 | 2642 / 2642 | 100% | 95.87 | 704 / 705 |
lung | 100% | 11444.95 | 578 / 578 | 99% | 31.55 | 1149 / 1155 |
kidney | 100% | 5749.97 | 89 / 89 | 99% | 41.59 | 888 / 901 |
thymus | 100% | 9467.69 | 653 / 653 | 98% | 33.31 | 595 / 605 |
breast | 100% | 8812.27 | 459 / 459 | 98% | 31.54 | 1097 / 1118 |
bladder | 100% | 8529.95 | 21 / 21 | 98% | 23.89 | 494 / 504 |
pancreas | 100% | 4545.02 | 328 / 328 | 98% | 26.90 | 174 / 178 |
skin | 100% | 8779.64 | 1808 / 1809 | 97% | 45.04 | 457 / 472 |
intestine | 100% | 7133.89 | 966 / 966 | 96% | 21.31 | 507 / 527 |
uterus | 100% | 9296.19 | 170 / 170 | 95% | 23.30 | 438 / 459 |
stomach | 99% | 4777.26 | 356 / 359 | 96% | 23.55 | 275 / 286 |
prostate | 100% | 5618.52 | 244 / 245 | 95% | 17.88 | 479 / 502 |
adrenal gland | 100% | 5968.66 | 258 / 258 | 92% | 26.28 | 212 / 230 |
liver | 100% | 3201.07 | 225 / 226 | 80% | 12.39 | 326 / 406 |
ovary | 100% | 9540.26 | 180 / 180 | 65% | 8.04 | 279 / 430 |
adipose | 100% | 9931.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9598.45 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 12604.74 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4936.56 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.92 | 1 / 1 |
heart | 97% | 5129.79 | 837 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 23.63 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 91% | 26.72 | 73 / 80 |
peripheral blood | 89% | 4109.78 | 827 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 12.52 | 24 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000165 | Biological process | MAPK cascade |
GO_1903860 | Biological process | negative regulation of dendrite extension |
GO_0051146 | Biological process | striated muscle cell differentiation |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0045665 | Biological process | negative regulation of neuron differentiation |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0032418 | Biological process | lysosome localization |
GO_0045666 | Biological process | positive regulation of neuron differentiation |
GO_0001669 | Cellular component | acrosomal vesicle |
GO_0034451 | Cellular component | centriolar satellite |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0008432 | Molecular function | JUN kinase binding |
GO_0005078 | Molecular function | MAP-kinase scaffold activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0030159 | Molecular function | signaling receptor complex adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0019894 | Molecular function | kinesin binding |
Gene name | SPAG9 |
Protein name | Sperm associated antigen 9 variant 5 C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1) Sperm associated antigen 9 |
Synonyms | HLC6 SYD1 KIAA0516 MAPK8IP4 HSS |
Description | FUNCTION: The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module . Regulates lysosomal positioning by acting as an adapter protein which links PIP4P1-positive lysosomes to the dynein-dynactin complex . Assists PIKFYVE selective functionality in microtubule-based endosome-to-TGN trafficking (By similarity). . |
Accessions | ENST00000262013.12 [O60271-1] ENST00000510283.5 [O60271-9] ENST00000357122.8 [O60271-4] ENST00000513906.1 H0YBS5 ENST00000511795.1 A0A060L980 ENST00000505279.5 [O60271-2] H0YBE9 O60271 ENST00000510855.1 ENST00000513746.6 D6RHI8 H0Y981 |